Consainsights logo
Reports / Peptide Therapeutics Market

Peptide Therapeutics Market

Peptide Therapeutics Market Research Report – Segmented By Marketing Type (Branded, Generic), Application (Cancer, Gastrointestinal Disorders, Metabolic Disorders, Neurological Disorders, Other Applications), Route of Administration (Oral, Other Routes of Administration, Parenteral) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Peptide Therapeutics Market was valued at US $35.68 billion in 2021 and is projected to grow at 7.16% CAGR over the forecast period to reach US $54.02 billion by 2027. Peptide Therapeutics Market represented US $4.61 billion opportunity over 2019-2021 and estimated to create US $18.34 billion opportunity in 2027 over 2021.

Peptide Therapeutics from Consainsights analyses the Peptide Therapeutics Market in the Life Sciences industry over the forecast period to 2027.

Peptide Therapeutics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Peptide Therapeutics segmentation includes Marketing Type, Application, Route of Administration and Geography.

Based on the Marketing Type, the Peptide Therapeutics analysis covers Branded, Generic.

In Marketing Type segment, Branded segment has highest cagr growth of 6.34%.

Based on the Application, the Peptide Therapeutics analysis covers Cancer, Other Applications, Metabolic Disorders, Neurological Disorders, Gastrointestinal Disorders.

In Application segment, Cancer segment has highest cagr growth of 6.34%.

Based on the Route of Administration, the Peptide Therapeutics analysis covers Oral, Parenteral, Other Routes of Administration.

In Route of Administration segment, Oral segment has highest cagr growth of 6.34%.

Based on the region, the Peptide Therapeutics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Sanofi SA, Amgen Inc., Novartis AG, Pfizer Inc., AmbioPharm Inc., AstraZeneca PLC, Novo Nordisk AS, PeptiDream Inc., Arch NioPartners, Bachem Holding AG, CirclePharma Inc., PolyPeptide Group, Zealand Pharma AG, Apitope Technology, GlaxoSmithKline PLC, Eli Lilly and Company, Amylin Pharmaceuticals, Ever Neuro Pharma GmbH, Galena Biopharmaceuticals, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd, Takeda Pharmaceutical Company Limited and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Marketing Type (2021)
    Revenue Share (%), By Marketing Type (2021)
  • Revenue Share (%), By Application (2021)
    Revenue Share (%), By Application (2021)
  • Revenue Share (%), By Route of Administration (2021)
    Revenue Share (%), By Route of Administration (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Marketing Type

  • Branded accounted for US$20.96 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Generic accounted for US$14.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Marketing Type 2019 - 2027
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Marketing Type 2019 - 2027
Peptide Therapeutics Market Size, By Marketing Type, 2019-2027 (USD billion)
Peptide Therapeutics Market Size, By Marketing Type, 2019-2027 (USD billion)

The Branded segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Branded: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Branded: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Generic segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Generic: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Generic: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
04

By Application

  • Cancer accounted for US$14.96 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Other Applications accounted for US$9.22 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Metabolic Disorders accounted for US$4.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Neurological Disorders accounted for US$4.92 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Gastrointestinal Disorders accounted for US$2.04 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Application 2019 - 2027
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Application 2019 - 2027
Peptide Therapeutics Market Size, By Application, 2019-2027 (USD billion)
Peptide Therapeutics Market Size, By Application, 2019-2027 (USD billion)

The Cancer segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Cancer: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Cancer: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Gastrointestinal Disorders segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Gastrointestinal Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Gastrointestinal Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Metabolic Disorders segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Metabolic Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Metabolic Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Neurological Disorders segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Neurological Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Neurological Disorders: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Other Applications segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Applications: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Other Applications: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
05

By Route of Administration

  • Oral accounted for US$16.49 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Parenteral accounted for US$9.06 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Other Routes of Administration accounted for US$10.14 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Route of Administration 2019 - 2027
Peptide Therapeutics Market Y-o-Y Growth (USD billion), By Route of Administration 2019 - 2027
Peptide Therapeutics Market Size, By Route of Administration, 2019-2027 (USD billion)
Peptide Therapeutics Market Size, By Route of Administration, 2019-2027 (USD billion)

The Oral segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Oral: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Oral: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Other Routes of Administration segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Other Routes of Administration: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Other Routes of Administration: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)

The Parenteral segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Parenteral: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
Parenteral: global Peptide Therapeutics Market Revenue Opportunity (Us$ Mn)
06

North America

  • In 2021, North America segment accounted for US$35.68 Bn and is expected grow with a CAGR of 7.16% over the forecast years.
  • In North America, United States accounted for US$25.31 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$10.38 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
North America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
North America Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Marketing Type - North America (2021)
Revenue Share (%), By Marketing Type - North America (2021)
Revenue Share (%), By Application - North America (2021)
Revenue Share (%), By Application - North America (2021)
Revenue Share (%), By Route of Administration - North America (2021)
Revenue Share (%), By Route of Administration - North America (2021)
North America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
North America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United States Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Canada Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
07

Europe

  • In 2021, Europe segment accounted for US$35.68 Bn and is expected grow with a CAGR of 7.16% over the forecast years.
  • In Europe, Germany accounted for US$14.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$8.87 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$5.37 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$2.98 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$2.02 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$1.81 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.11 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Europe Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Europe Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Marketing Type - Europe (2021)
Revenue Share (%), By Marketing Type - Europe (2021)
Revenue Share (%), By Application - Europe (2021)
Revenue Share (%), By Application - Europe (2021)
Revenue Share (%), By Route of Administration - Europe (2021)
Revenue Share (%), By Route of Administration - Europe (2021)
Europe Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Europe Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Germany Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
United Kingdom Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
France Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Spain Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Russia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Italy Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Europe Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
08

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$35.68 Bn and is expected grow with a CAGR of 7.16% over the forecast years.
  • In Asia-Pacific, China accounted for US$14.68 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$8.14 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$5.36 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$4.25 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$2.72 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.53 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Marketing Type - Asia-Pacific (2021)
Revenue Share (%), By Marketing Type - Asia-Pacific (2021)
Revenue Share (%), By Application - Asia-Pacific (2021)
Revenue Share (%), By Application - Asia-Pacific (2021)
Revenue Share (%), By Route of Administration - Asia-Pacific (2021)
Revenue Share (%), By Route of Administration - Asia-Pacific (2021)
Asia-Pacific Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
China Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Japan Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
India Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Southeast Asia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Australia & New Zealand Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Asia-Pacific Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
09

Middle East & Africa

Based on the Middle East & Africa, the Peptide Therapeutics Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Peptide Therapeutics Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Peptide Therapeutics Size, 2019-2027 (Us$ Mn)
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Middle East Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Middle East & Africa Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
10

Latin America

  • In 2021, Latin America segment accounted for US$35.68 Bn and is expected grow with a CAGR of 7.16% over the forecast years.
  • In Latin America, Brazil accounted for US$16.56 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$8.58 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$7.51 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$2.20 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$0.83 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Latin America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Latin America Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Peptide Therapeutics Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Marketing Type - Latin America (2021)
Revenue Share (%), By Marketing Type - Latin America (2021)
Revenue Share (%), By Application - Latin America (2021)
Revenue Share (%), By Application - Latin America (2021)
Revenue Share (%), By Route of Administration - Latin America (2021)
Revenue Share (%), By Route of Administration - Latin America (2021)
Latin America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Latin America Peptide Therapeutics Market, By Country, 2019-2027 (USD billion)
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Brazil Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Argentina Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Mexico Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Colombia Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Marketing Type, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Application, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
Rest of Latin America Peptide Therapeutics Market - Historical, Forecast Market Sizes (US$ MN), By Route of Administration, 2019-2027
11

Company Analysis

  • Sanofi SA
  • Amgen Inc.
  • Novartis AG
  • Pfizer Inc.
  • AmbioPharm Inc.
  • AstraZeneca PLC
  • Novo Nordisk AS
  • PeptiDream Inc.
  • Arch NioPartners
  • Bachem Holding AG
  • CirclePharma Inc.
  • PolyPeptide Group
  • Zealand Pharma AG
  • Apitope Technology
  • GlaxoSmithKline PLC
  • Eli Lilly and Company
  • Amylin Pharmaceuticals
  • Ever Neuro Pharma GmbH
  • Galena Biopharmaceuticals
  • Bristol-Myers Squibb Company
  • Teva Pharmaceuticals Industries Ltd
  • Takeda Pharmaceutical Company Limited